Overview
Chronic leukemia encompasses chronic lymphocytic leukemia (CLL) and chronic myeloid leukemia (CML), characterized by the gradual accumulation of mature but functionally impaired leukocytes, leading to progressive cytopenias and potential organ dysfunction.Diagnosis
Clinical Presentation: Fatigue, recurrent infections, lymphadenopathy, hepatosplenomegaly 4.
Laboratory Tests: Full blood count showing lymphocytosis (CLL) or elevated white blood cell count with myeloid predominance (CML), bone marrow biopsy 43.
Imaging: CT or MRI for organ involvement, particularly in gastrointestinal manifestations 4.
Specific Conditions: Hypercalcemia may occur in CLL without typical triggers like blastic transformation or hyperparathyroidism 2.Management
First-Line Treatments:
- CLL: Chemoimmunotherapy (e.g., fludarabine, cyclophosphamide, rituximab) 4 (Evidence: Moderate).
- CML: Tyrosine kinase inhibitors (e.g., imatinib) 3 (Evidence: Strong).
Adjunctive Treatments:
- Pain management and palliative care, including palliative sedation when appropriate 1 (Evidence: Weak).
- Monitoring devices like NeuroSense and Analgesia Nociception Index for assessing comfort and pain in sedated patients 1 (Evidence: Weak).Special Populations
Elderly: Increased risk of complications; careful titration of sedatives and analgesics is crucial 1 (Evidence: Weak).
Comorbidities: Hypercalcemia in CLL patients requires specific monitoring and management distinct from other causes 2 (Evidence: Moderate).Key Recommendations
Use tyrosine kinase inhibitors as first-line therapy for chronic myeloid leukemia (CML) to target the underlying molecular defect (Evidence: Strong) 3.
Implement monitoring devices alongside traditional scales to improve assessment of comfort and pain in sedated palliative care patients, especially in those with limited verbal communication (Evidence: Weak) 1.
Closely monitor for hypercalcemia in chronic lymphocytic leukemia patients, recognizing it can occur independently of common triggers like blastic transformation (Evidence: Moderate) 2.References
1 Six S, Laureys S, Poelaert J, Bilsen J, Theuns P, Musch L et al.. Should we include monitors to improve assessment of awareness and pain in unconscious palliatively sedated patients? A case report. Palliative medicine 2019. link
2 Macintyre EA. Hypercalcaemia in chronic lymphatic leukaemia. Postgraduate medical journal 1986. link
3 Lysy J, Globus M, Okon E, Polliack A, Chowers I. Solitary intracranial chloroma in a patient with chronic granulocytic leukemia. Neurology 1983. link
4 Lahti R, Lehtola J, Suramo I. Gastrointestinal manifestations of chronic lymphatic leukemia. Diagnostic imaging 1979. link